M

Researcher Profile

Mireille Mpoudi-Etame

1

Publications

144

Citations

10

Co-Authors

1

Active Years

Publications

Journal Article The Lancet HIV Oct 01, 2020

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy · Tamara Tovar Sanchez · Charles Kouanfack · Mireille Mpoudi-Etame +76 more

10.1016/s2352-3018(20)30238-1 144 citations

Publication Timeline

2020

1

Frequent Co-Authors

Noémie Mercier

Martine Peeters

M Lantche-Wandji

Martial Lantche Wandji